公开(公告)号：EP0760674A1

公开(公告)日：1997-03-12

申请号：EP95914824.0

申请日：1995-03-27

Applicant: ABBOTT LABORATORIES

Inventor： MUKERJI, Pradip ,  SEO, Amanda, Eun-Yeong ,  ANDERSON, Steven, Neal ,  SCHALLER, Joseph, Paul

IPC: A23L1 ,  A61K38 ,  A61P11 ,  A61P31 ,  C07H21 ,  C07K14

CPC classification number: A61K38/018 ,  A23L33/19 ,  C07K14/4732

Abstract: The infection of mammalian cells by RSV may be inhibited by native human β-casein, a recombinant form of human β-casein, and hydrolysates of both. The human β-casein or hydrolysate may be contained in a liquid enteral nutritional product such as an infant formula. The enteral nutritional product may be used, for example, in the prevention and treatment of respiratory tract infection in infants. The human β-casein or hydrolysate may also be administered as a throat spray or nasally using drops or a spray.